🇺🇸 PTGX — Protagonist Therapeutics, Inc.

Salud Compra fuerte
← Volver

Precio actual

140,24 USD

Máx. histórico

158,62

78 días

Caída desde máximo

-11,59%

Rango 52 semanas

75,44 – 160,81

Variación hoy

+0,62%

Cierre anterior

139,37

Rango de hoy

139,91 – 144,27

Volumen hoy

673.087

Peor caída histórica

-85,79%

01/09/2021 → 13/06/2022

Recuperado en 1001 días

Volatilidad anualizada ⓘ

89,34%

Información
Nombre completo
Protagonist Therapeutics, Inc.
Divisa
USD
Mercado
NasdaqGM
Sector
Salud
Industria
Biotechnology
Empleados
141
PER ⓘ
136,16 (puede no estar actualizado)
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
178,57 USD (puede no estar actualizado)
Primera cotización
11/08/2016
Precio actualizado
hace 12 horas
Sobre la empresa

Protagonist Therapeutics, Inc. operates as a discovery and development company in the United States. It develops Icotyde, a first-in-class investigational targeted oral peptide for the treatment of adults and pediatric patients 12 years of age and older with moderate-to-severe plaque psoriasis; and Rusfertide, a first-in-class investigational injectable mimetic of the natural hormone hepcidin in Phase 3 development for the treatment of the rare blood disorder polycythemia vera. The company is also developing PN-881, a potential best-in-class oral peptide IL-17 antagonist, for the treatment of immune-mediated skin diseases in Phase 1 clinical trials; PN-477 and PN-458, which are development candidates for the treatment of obesity; PN-8047, an orally administered hepcidin functional mimetic small molecule; L-4R alpha antagonist for the treatment of atopic dermatitis and moderate-to-severe asthma; and amylinR-based oral and subcutaneous mono- and poly-agonists for the treatment of obesity. Protagonist Therapeutics, Inc. was incorporated in 2006 and is headquartered in Newark, California.

Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
09/09/2024 42,53 44,96 42,39 44,59 +7,45% 6,05% 1.031.200
06/09/2024 42,07 42,60 41,38 41,50 -1,24% 2,90% 475.600
05/09/2024 41,63 42,08 41,00 42,02 +0,53% 2,59% 400.800
04/09/2024 41,40 42,33 40,89 41,80 +0,94% 3,49% 614.800
03/09/2024 42,32 43,56 40,67 41,41 -3,45% 6,83% 578.800
30/08/2024 42,29 43,09 42,05 42,89 +1,42% 2,47% 497.300
29/08/2024 42,72 43,76 42,16 42,29 -1,08% 3,75% 394.200
28/08/2024 42,43 43,31 42,04 42,75 +1,16% 2,99% 442.300
27/08/2024 41,51 42,35 41,26 42,26 +1,59% 2,63% 390.300
26/08/2024 41,91 42,07 41,14 41,60 -0,19% 2,21% 361.900
23/08/2024 41,70 41,85 40,80 41,68 +0,58% 2,51% 698.000
22/08/2024 41,49 42,26 40,89 41,44 -0,26% 3,30% 558.300
21/08/2024 41,68 42,04 41,11 41,55 +0,12% 2,22% 739.900
20/08/2024 42,10 42,10 41,06 41,50 -0,95% 2,47% 511.900
19/08/2024 41,40 42,30 41,12 41,90 +1,21% 2,85% 502.500
16/08/2024 40,46 41,94 40,10 41,40 +2,00% 4,55% 930.800
15/08/2024 41,07 41,12 40,36 40,59 +0,87% 1,85% 664.100
14/08/2024 40,42 41,10 39,91 40,24 -0,17% 2,94% 611.000
13/08/2024 41,11 41,34 39,74 40,31 -0,71% 3,89% 635.200
12/08/2024 38,83 41,00 38,32 40,60 +4,86% 6,91% 695.000
09/08/2024 37,50 39,15 37,41 38,72 +4,14% 4,64% 1.063.500
08/08/2024 36,14 37,34 35,21 37,18 +3,88% 5,88% 530.400
07/08/2024 36,63 38,85 35,72 35,79 -1,16% 8,54% 820.300
06/08/2024 35,38 36,40 34,74 36,21 +1,17% 4,71% 399.100
05/08/2024 34,51 36,80 32,50 35,79 -4,20% 12,46% 1.002.400
02/08/2024 36,21 37,49 35,05 37,36 -1,58% 6,74% 591.600
01/08/2024 37,42 38,57 36,65 37,96 +1,39% 5,13% 835.900
31/07/2024 37,85 38,62 36,92 37,44 -0,56% 4,49% 627.400
30/07/2024 38,86 39,53 37,47 37,65 -2,99% 5,30% 412.500
29/07/2024 39,97 40,41 38,60 38,81 -3,65% 4,53% 727.100